• Home
  • News
    • Editorial
    • MD(e)B(unker)
    • Related Researches
      • Di Bella's Foundation
      • 1960-1969
      • 1970-1979
      • 1980-1989
      • 1990-1999
      • 2000-2009
      • 2010-2019
      • 2020-2029
    • Science news
    • Scientific Documentation
  • About us...
    • Biography
    • Bibliography
  • The Method
    • Di Bella's Method!
    • 1998 Trial!
  • Media
    • Video Publications
    • News-PapersNews-Papers
      • Press
    • TestimonialTestimonial
      • Testimonies
    • Video GalleryVideo Gallery
      • Congresses
      • Video Testimonies
      • TV & C.
  • Case History
    • Medical reports
      • Lung
      • Lymphomas
        • Non-Hodgkin Lymphomas
        • Hodgkin Lymphomas
      • Mediastinum
      • Mesothelioma
      • Myeloma
      • Pancreas
      • Scientific Publications
  • F.A.Q.
  • Useful Links
    • User Side
      • Vademecum
    • CouponChief - Resources for Cancer Patients
  • Contact Us
Home page   News   Related Researches   2010-2019  
Title Created Date
Molecular mechanisms and biomedical applications of glucosamine as a potential multifunctional therapeutic agent 08 June 2022
Anti-cancer activity of glucosamine through inhibition of N-linked glycosylation 02 June 2022
Neonatal vitamin D and childhood brain tumor risk 25 May 2022
Initial Experience With Gallium-68 DOTA-Octreotate PET/CT and Peptide Receptor Radionuclide Therapy for Pediatric Patients With Refractory Metastatic Neuroblastoma 20 April 2022
Screening for vitamin D insufficiency in pediatric cancer survivors 08 April 2022
Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study 23 March 2022
Minireview: Extrapituitary prolactin: an update on the distribution, regulation, and functions 16 March 2022
The prolactin receptor as a therapeutic target in human diseases: browsing new potential indications 04 March 2022
Melatonin MT1 and MT2 receptors display different molecular pharmacologies only in the G-protein coupled state 25 February 2022
Role of EGF/ERBB1 in the transcriptional regulation of the prolactin receptor independent of estrogen and prolactin in breast cancer cells 25 February 2022
Display # 

Page 14 of 173

  • Start
  • Prev
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • Next
  • End

Search

Follow us...

Latest

  • Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells
  • Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis
  • High-dose vitamin C (ascorbic acid) therapy in the treatment of patients with advanced cancer
  • The impact of vitamin D on cancer: A mini review
  • Solution of retinoids in vitamin E in the Di Bella Method biological multitherapy
  • Somatostatin and Somatostatin Receptors in Tumour Biology
  • Immunohistochemical expression of somatostatin receptor subtypes in prostate tissue from cystoprostatectomies with incidental prostate cancer
  • Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies
  • Androgen Receptor Regulation of Local Growth Hormone in Prostate Cancer Cells
  • An updated review of mechanistic potentials of melatonin against cancer: pivotal roles in angiogenesis, apoptosis, autophagy, endoplasmic reticulum stress and oxidative stress
  • Vitamin D Status in Pediatric Oncology Patients in Lebanon: A Comparison With Non-oncology Controls in a Case-Control Study
  • Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization
  • Melatonin and cancer: From the promotion of genomic stability to use in cancer treatment
  • Targeting Melatonin to Mitochondria Mitigates Castration-Resistant Prostate Cancer by Inducing Pyroptosis
  • Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions
  • Is Melatonin the "Next Vitamin D"?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements
  • Programmed cell death and melatonin: A comprehensive review
  • Beneficial properties of melatonin in an experimental model of pancreatic cancer

Most Read

  • The Di Bella Method (DBM)
  • About melatonin - 1996
  • All-trans-retinoic acid and cancer
  • Biography
  • Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
  • Somatostatin in oncology, the overlooked evidences
  • The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
  • Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
  • Bibliography
  • Complete objective response to biological therapy of plurifocal breast carcinoma
  • How effective is chemo therapy?
  • Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
  • Vademecum
  • Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
  • Frequently Asked Questions
  • Declaration recommends eliminate the use of Impact factor for research evaluation
  • Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
  • Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer